Skip to main content Back to Top
Advertisement

12/6/2023

Diclofenac 0.1% Ophthalmic Solution

Products Affected - Description

    • Diclofenac sodium ophthalmic solution, Bausch Health, 0.1%, 5 mL bottle, NDC 24208-0457-05
    • Diclofenac sodium ophthalmic solution, Rising Pharmaceuticals, 0.1%, 2.5 mL bottle, NDC 16571-0101-25 - discontinued
    • Diclofenac sodium ophthalmic solution, Rising Pharmaceuticals, 0.1%, 5 mL bottle, NDC 16571-0101-50 - discontinued

Reason for the Shortage

    • Rising pharmaceuticals discontinued diclofenac ophthalmic solution.
    • Sandoz has diclofenac available.

Available Products

    • Diclofenac sodium ophthalmic solution, Sandoz, 0.1%, 2.5 mL bottle, NDC 61314-0014-25
    • Diclofenac sodium ophthalmic solution, Sandoz, 0.1%, 5 mL bottle, NDC 61314-0014-05

Estimated Resupply Dates

    • Bausch Health has diclofenac 1% ophthalmic solution in 5 mL bottles on backorder and the company cannot estimate a release date.

Updated

Updated December 6, 2023 by Rachael Freeman, PharmD, BCPS. Created February 8, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.

ADVERTISEMENT